Biofourmis
Jeff Clarke serves as the Executive Chairman of Doxim, a role held since November 2022, and previously held the position of Interim CEO until February 2024. Clarke's extensive experience includes being a member of the Board of Directors of Travelport, a role that spans from 2006 to present, alongside serving as Chairman and Executive Chairman during different periods. Clarke also holds board positions at Mondee and Columbia Care since September 2023 and February 2020, respectively. Previously, Clarke acted as Interim CEO and Board Member for FTD, Co-CEO of E.Merge Technology Acquisition Corporation, and held leadership roles at Generate Life Sciences and Docker, Inc. Clarke's executive experience extends to serving as CEO of Eastman Kodak and holding board positions at Autodesk. An MBA graduate from Northeastern University and a BA in Economics from SUNY Geneseo, Clarke's diverse background encompasses leadership across various sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Biofourmis
6 followers
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.